Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

Ergocalciferol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ergocalciferol and what is the scope of freedom to operate?

Ergocalciferol
is the generic ingredient in four branded drugs marketed by West Ward, Sigmapharm Labs Llc, Bionpharma Inc, Lannett, Orit Labs Llc, Us Pharm Holdings, Chase Chem, Impax Labs, Vitarine, Strides Pharma, Everylife, Sun Pharm Inds Inc, and Lilly, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ergocalciferol. Thirty-five suppliers are listed for this compound.

Summary for Generic Name: ergocalciferol

Tradenames:4
Patents:1
Applicants:13
NDAs:13
Drug Master File Entries: see list5
Suppliers / Packagers: see list35
Bulk Api Vendors: see list34
Clinical Trials: see list12
Patent Applications: see list7,027
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ergocalciferol at DailyMed

Pharmacology for Ingredient: ergocalciferol

Ingredient-typeErgocalciferols
Drug ClassProvitamin D2 Compound
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vitarine
VITAMIN D
ergocalciferol
CAPSULE;ORAL084053-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
West Ward
VITAMIN D
ergocalciferol
CAPSULE;ORAL083102-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Orit Labs Llc
ERGOCALCIFEROL
ergocalciferol
CAPSULE;ORAL040833-001May 20, 2009AARXNoNo► Subscribe► Subscribe
Everylife
VITAMIN D
ergocalciferol
CAPSULE;ORAL080956-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
DELTALIN
ergocalciferol
CAPSULE;ORAL080884-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot